Contract notice: Research laboratory services Tender, Finland - 24786435

Procurement Summary

Country : Finland

Summary : Contract notice: Research laboratory services

Deadline : 31 Aug 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 24786435

Document Ref. No. : 292118-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ
Office Name: Helsingin ja Uudenmaan sairaanhoitopiirin kuntayhtymä
Address: PL 441, HUS (Uutistie 5, 01770 Vantaa)
Town: Helsinki
Postal Code: 00029
Contact Point: Vanessa Räsänen

Phone: +358 94711

Finland
Email :vanessa.rasanen@hus.fi
URL :http://www.hus.fi

Tender Details

Object of the contract
Research laboratory services

Description: Contract notice: Research laboratory services

Authority Type: Other
Contact Nature: Services
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 73111000, 73111000, 73111000
CPV Description: Research Laboratory Services

HUSLAB Drug Studies

Reference Number: HUS 063-2018

Acquisition of drug studies for HUSLAB. HUSLAB acquires drug studies that are not economically or technically feasible or feasible in HUSLAB's own laboratories. The studies that are the subject of the procurement are listed in Annex 1. Most of them are taintedThe investigations into the chronic conditions are described in the HUSLAB online manual.

Acquisition of drug studies, extensive screening 103003 U -HuumTOF (21281). U -HuumTOF research provider should be able to offer research analyzes of narcotic drugs and herbal substances. A compulsory requirement is a skeptical result statement.

U -HuumTOF, U -HuumLCt and B -LaThe seam codes of the eagle should be the same as those of the current HUSLAB screened screeners (see HUSLAB's manual, as well as the U-HuumLct current loops). U-HuumTOF, U-HuumLCt and B -LaeaekHu

should be indicated on the offer and HUSLAB reserves the right to evaluate the sufficiency and suitability of the HUSLAB requirements for customer needsdreaming. Details of each method can be presented in a separate annex. The reporting limits for the most common analytes in U -HuumTOF, U-HuumLCt and B -LaeaekHu

must be reported, they must state the requirements specified for the individual drugs specified in the research attachment document and HUSLAB reserves the right to evaluate their suitability for absoluterelying on the requirements set out in the The characteristics of each method can be presented in a separate annex.

In the case of a large screen, the bid must describe the measures that will ensure the provider's assurance of the timeliness and completeness of the menu. The bidding process will likewise be used to introduce a new protocol for the study of compounds. The subject of the acquisition is divided into sections
Internet address (URL): http://www.hus.fi

Documents

 Tender Notice